Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex
- 22 February 1992
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 339 (8791), 453-456
- https://doi.org/10.1016/0140-6736(92)91058-g
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Immunopathogenesis of HIV infectionThe FASEB Journal, 1991
- Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndromeAmerican Journal Of Medicine, 1991
- Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.BMJ, 1991
- Analysis of serial measurements in medical research.BMJ, 1990
- Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome.JCI Insight, 1989
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- LONG-TERM FOLLOW-UP OF SERUM-INTERFERON AND ITS ACID-STABILITY IN A GROUP OF HOMOSEXUAL MENAIDS Research, 1986
- ROLE OF INTERFERON IN AIDSAnnals of the New York Academy of Sciences, 1984
- Race- and sex-specific reference data for triceps and subscapular skinfolds and weight/statureThe American Journal of Clinical Nutrition, 1982
- [52] Virus yield-reduction assays for interferon: Picornavirus hemagglutination measurementsMethods in enzymology, 1981